MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life-sciences research, today announced that the Abraxis Melamine Detection Kit has been validated for use on MDS Analytical Technologies’ SpectraMax® absorbance microplate readers with SoftMax® Pro 5 GxP analytical software, an industry-standard analysis software for FDA 21 CFR Part 11 compliance.
Navigation
Daily News
- Public Engagement Grants 2010 – Applications Open – British Psychological Society
- New Report Published On Social Care, England
- Are Cities Designed For Women? Penn-ICOWHI Conference Examines Urban Women’s Health
- Stimuvax Will Become Decision Resources’ Proprietary Clinical Gold Standard For The Treatment Of Locally Advanced Non-Small-Cell Lung Cancer
- Researchers Develop Tool To Help Study Prostate Cancer
Translator
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  | ||
| By N2H | |||||||||